Loading
Varegacestat is an experimental small-molecule drug from Immunome in phase 3 trials for desmoid tumour, with its target not yet stated publicly.
Varegacestat (AL102) is a small-molecule drug developed by Immunome. The sponsor describes its target as gamma secretase / Notch signalling, which OnCo does not yet have a target page for. The sponsor states: AL102 (varegacestat) is a small-molecule inhibitor of gamma secretase-mediated Notch signalling. ClinicalTrials.gov describes the intervention as: AL102 is an inhibitor of gamma secretase-mediated Notch signaling. It is the investigational product in 1 recruiting or active industry-led phase 2 and phase 3 interventional cancer trial, including the phase 3 study NCT04871282 (A Study of AL102 in Patients With Progressing Desmoid Tumours), in desmoid tumour. The largest, NCT04871282, plans to enrol 198 participants (actual) with primary completion was scheduled for 2025-12-03 on the registry. Status reflects the highest phase registered on ClinicalTrials.gov; no efficacy results are recorded here.
AL102 (varegacestat) is a small-molecule inhibitor of gamma secretase-mediated Notch signalling.
1.Varegacestat slips into a pocket on its target.
Background: ADC sequencing, Antigen escape (antigen loss, lineage switch), BCG-unresponsive, Castration-resistant prostate cancer (CRPC), Circulating tumour DNA (ctDNA). Also on OnCo: Resistance: how tumours escape each drug class · Lines of therapy.
Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.
Query for this drug: (TITLE:"Varegacestat" OR ABSTRACT:"Varegacestat" OR TITLE:"AL102" OR ABSTRACT:"AL102") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Varegacestat, not a curated reading list.
Shares Desmoid tumour and the tag pipeline.
Shares Immunome, Desmoid tumour.